North Carolina H1000

Right to public transparency. (a) Any gender clinic operating in the State must provide a report of statistics regarding all surgical gender transition procedures and prescribed regimens of cross-sex hormones or puberty-blocking drugs to patients to the Department. (b) The Department shall develop a form for this purpose and determine the statistics to be reported, which must include the following: (1) The date on which the surgical gender transition procedure or prescribed regimen of cross-sex hormones or puberty-blocking drugs was prescribed or the referral was made for either. (2) The age and sex of the person to whom the surgical gender transition procedure or prescribed regimen of cross-sex hormones or puberty-blocking drugs was prescribed or for whom the referral was made for either. (3) For any cross-sex hormone or puberty-blocking drug prescribed as part of a gender transition, (i) the name of the drug or hormone, (ii) the dosage, (iii) the dosage frequency and duration, and (iv) the method by which the drug will be administered. (4) For any surgical gender transition procedure, the type of surgical procedure, identified by current procedural terminology code. (5) The state and county of residence of the person receiving the surgical gender transition procedure or regimen of cross-sex hormones or puberty-blocking drugs. (6) The name, contact information, and medical specialty of the medical professional who prescribed the (i) surgical gender transition procedure or (ii) regimen of cross-sex hormones or puberty-blocking drugs or made the referral for either. (7) If applicable, a description of any other neurological, behavioral, or mental health conditions that the person has been diagnosed with or exhibits symptoms of, including autism spectrum disorder, depressions, anxiety, or bipolar disorder.

All health benefit plans that provide coverage for one or more gender transition procedures for insureds who are minors, including coverage for any applicable related diagnostic, billing, or CPT code, shall also provide coverage for all of the following: (1) All possible adverse consequences related to the gender transition procedure, including both short-term and long-term side effects of the procedure. (2) Testing and screening necessary to monitor the mental health and physical health of any insured on no less than an annual basis and without regard to the sex designation on the insured's medical record. (3) Any procedure or treatment, including therapy, necessary to manage, reverse, or recover from the insured's previous gender transition procedure. (c) Coverage required under this section shall be provided to all insureds that underwent a gender transition procedure as a minor regardless of whether that gender transition procedure occurred when the individual was not insured under the current health benefit plan. (d) On at least an annual basis, an insurer offering one or more health benefit plans that provide coverage for gender transition or detransition procedures shall provide the following information, if known, to the Commissioner and the Secretary of the Department of Health and Human Services in a manner determined by the Commissioner or the Secretary and that contains no protected health information nor personally identifiable information: (1) The number of claims made for a gender transition or detransition procedure. (2) The age and sex of the individuals for whom a gender transition or detransition procedure claim is submitted. (3) The date that the individual for whom a detransition procedure claim is submitted initially began a prior gender transition procedure. (4) The county of residence of the person for whom the gender transition or detransition procedure claim is submitted